Transparency
We strive to apply the highest standards of ethics and integrity to everything we do.
As a pharmaceutical company, our work requires us to cultivate strong relationships with customers, partners, employees and stakeholders – and confidence among the general public. We’re working every day to earn that trust. Providing transparent information about our company is part of that endeavor.
Our parent company in the United States communicates proactively and in detail:
- in our Financial Reports and Corporate Responsibility Reports
- by registering all clinical trials at www.clinicaltrials.gov and publishing the results
- through the media
At national level, we publish the support of patient organizations since 2011. Additionally from 2016, we disclose annually our transfers of value to health care professionals and health care organizations.
Transfers of value to health care professionals and health care organizations
2023
MSD Methodology Statement
MSD Report 2023
MSD Self-Certification Letter, issued by Merck & Co., Inc., Rahway, NJ, USA
2022
MSD Methodology Statement
MSD Report 2022
MSD Self-Certification Letter, issued by Merck & Co., Inc., Rahway, NJ, USA
2021
MSD Methodology Statement
MSD Report 2021
MSD Self-Certification Letter, issued by Merck & Co., Inc., Rahway, NJ, USA
CH-NON-00866, 06/2024